The registry describes this research topic: “Trial of Dialectical Behaviour Therapy Interventions for Young People Experiencing Difficulty Regulating Emotions”. This is an interventional study.
In Robina
Why is this study shown?
This study is directly about Personality disorders.
Personality disordersBehavioralFrom 16 Years to 25 Years
The registry describes this research topic: “Evaluation of a peer and clinician co-facilitated group program for people with borderline personality disorder”. This is an interventional study.
In Australia
Why is this study shown?
This study is directly about Personality disorders.
Personality disordersOtherFrom 18 Years to No limit
Countries
Australia
Sponsor
The Project Air Strategy for Personality Disorders, University of Wollongong
The registry describes this research topic: “Treatment of borderline personality disorder with omega-3 fatty acids in combination with valproic acid”. This is an interventional study.
In Italy
Why is this study shown?
This study is directly about Personality disorders.
Personality disordersDrugFrom 18 Years to 65 Years
Countries
Italy
Sponsor
Centre for Personality Disorders, Psychiatric Clinic 1, Department of Neuroscience, University of Turin, Italy
The registry describes this research topic: “Estrogen for the treatment of Borderline Personality Disorder/Complex Post-Traumatic Stress Disorder”. This is an interventional study.
Multiple locations, including Melbourne
Why is this study shown?
This study is directly about Personality disorders.
Personality disorders, PTSDDrugFrom 18 Years to 60 Years
The registry describes this research topic: “Mother-Infant Dialectical Behaviour Therapy (MI-DBT) for mothers with borderline personality disorder”. This is an interventional study.
In Australia
Why is this study shown?
This study is directly about Personality disorders.
Personality disordersOtherFrom 16 Years to No limit
Countries
Australia
Sponsor
Helen Mayo House, Women's and Children's Health Network
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.